Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models Peinado, Paola Andrades Delgado, Álvaro Cuadros Celorrio, Marta Eugenia Rodríguez Lara, María Isabel García García, Daniel Jesús Álvarez Pérez, Juan Carlos Baliñas Gavira, Carlos Arenas Molina, Alberto Manuel Patiño Mercau, Juan Rodrigo Sanjuan Hidalgo, Juan Medina Vico, Pedro Pablo SWI/SNF complex Lung cancer Lung adenocarcinoma Epigenetics Cell model Multi-omics Simple Summary: Mammalian SWI/SNF complexes regulate gene expression by reorganizing the way DNA is packaged into chromatin. SWI/SNF subunits are recurrently altered in tumors at multiple levels, including DNA mutations as well as alteration of the levels of RNA and protein. Cancer cell lines are often used to study SWI/SNF function, but their patterns of SWI/SNF alterations can be complex. Here, we present a comprehensive characterization of DNA mutations and RNA and protein expression of SWI/SNF members in 38 lung adenocarcinoma (LUAD) cell lines. We show that over 85% of our cell lines harbored at least one alteration in one SWI/SNF subunit. In addition, over 75% of our cell lines lacked expression of at least one SWI/SNF subunit at the protein level. Our catalog will help researchers choose an appropriate cell line model to study SWI/SNF function in LUAD. Abstract: Mammalian SWI/SNF (SWitch/Sucrose Non-Fermentable) complexes are ATP-dependent chromatin remodelers whose subunits have emerged among the most frequently mutated genes in cancer. Studying SWI/SNF function in cancer cell line models has unveiled vulnerabilities in SWI/SNF-mutant tumors that can lead to the discovery of new therapeutic drugs. However, choosing an appropriate cancer cell line model for SWI/SNF functional studies can be challenging because SWI/SNF subunits are frequently altered in cancer by various mechanisms, including genetic alterations and post-transcriptional mechanisms. In this work, we combined genomic, transcriptomic, and proteomic approaches to study the mutational status and the expression levels of the SWI/SNF subunits in a panel of 38 lung adenocarcinoma (LUAD) cell lines. We found that the SWI/SNF complex was mutated in more than 76% of our LUAD cell lines and there was a high variability in the expression of the di erent SWI/SNF subunits. These results underline the importance of the SWI/SNF complex as a tumor suppressor in LUAD and the di culties in defining altered and unaltered cell models for the SWI/SNF complex. These findings will assist researchers in choosing the most suitable cellular models for their studies of SWI/SNF to bring all of its potential to the development of novel therapeutic applications. 2021-02-08T10:31:19Z 2021-02-08T10:31:19Z 2020-12-10 info:eu-repo/semantics/article Peinado, P., Andrades, A., Cuadros, M., Rodriguez, M. I., Coira, I. F., Garcia, D. J., ... & Medina, P. P. (2020). Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models. Cancers, 12(12), 3712. [doi:10.3390/cancers12123712] http://hdl.handle.net/10481/66378 10.3390/cancers12123712 eng http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess Atribución 3.0 España Mdpi